Which Iron Supplement is Better Tolerated?
Ferric maltol demonstrates the best tolerability profile with GI side effects comparable to placebo, while ferrous sulfate—though the most cost-effective first-line option—causes significantly more gastrointestinal side effects than placebo or IV iron. 1
Tolerability Hierarchy Based on Evidence
Best Tolerated: Ferric Maltol
- GI side effects and treatment cessation rates were comparable to placebo in patients with inactive IBD and moderate iron deficiency anemia 1
- In 12-week trials, ferric maltol normalized hemoglobin in 63-66% of cases with excellent tolerability 1
- The primary limitation is cost (£47.60 vs £1.00 for 28-day supply of ferrous sulfate), making it considerably more expensive than traditional iron salts 1
Standard First-Line: Ferrous Sulfate
- Ferrous sulfate significantly increases risk of GI side effects with an odds ratio of 2.32 versus placebo [95% CI 1.74-3.08, p<0.0001] and OR of 3.05 versus IV iron [95% CI 2.07-4.48, p<0.0001] 2
- Despite higher side effect rates, ferrous sulfate remains the gold standard due to cost-effectiveness and efficacy 1, 3
- The American College of Gastroenterology notes that no single formulation has proven advantages over others in terms of tolerability 4
Alternative Ferrous Salts
When comparing different oral iron formulations in a systematic review of 10,695 patients:
- Ferrous sulfate with mucoproteose had the lowest incidence of adverse effects (4.1% overall AEs, 3.7% GAEs) 5
- Ferrous fumarate had the highest incidence (47.0% overall AEs, 43.4% GAEs; OR: 19.87 compared to reference) 5
- Standard ferrous sulfate without mucoproteose: 32.3% overall AEs, 30.2% GAEs (OR: 11.21) 5
- Ferrous gluconate: 30.9% overall AEs, 29.9% GAEs (OR: 11.06) 5
- Iron protein succinylate: 7.3% overall AEs, 7.0% GAEs (OR: 1.96) 5
Comparing Ferrous vs Ferric Formulations
A head-to-head comparison found ferrous formulations more effective but with slightly higher GI side effects than ferric formulations 6:
- Blood test values improved significantly after switching from ferric to ferrous iron (p<0.01) 6
- However, ferric products generally have lower absorption rates 7
- One study found ferrous fumarate with ascorbic acid significantly more effective than ferric polysaccharide complex, with only slightly higher GI side effects 7
Critical Dosing Strategy to Improve Tolerability
Once-daily dosing of 50-100 mg elemental iron is recommended rather than multiple daily doses 1, 4:
- Short-term studies show that 60 mg elemental iron stimulates hepcidin levels, reducing subsequent iron absorption by 35-45% 1
- Overall absorption from 60 mg once daily was similar to 60 mg twice daily 1
- Alternate-day dosing leads to significantly increased fractional iron absorption compared to daily dosing in iron-depleted individuals 1, 4
Strategies to Minimize Side Effects
Timing and Co-Administration
- Taking iron with 250-500 mg vitamin C enhances absorption by forming a chelate with iron 4, 8
- Iron should be taken on an empty stomach to maximize absorption, though this increases GI side effects 4
- If GI side effects are intolerable, taking iron with food improves tolerability but decreases absorption 8
What to Avoid
- Avoid tea or coffee within an hour of iron intake (coffee decreases absorption by 54%) 8
- Avoid calcium-containing foods or medications with iron 4
- Modified-release preparations are indicated as "less suitable for prescribing" by the British National Formulary 1
Clinical Algorithm for Iron Selection
Start with ferrous sulfate 200 mg once daily (65 mg elemental iron) on an empty stomach 1, 4:
If intolerable GI side effects develop:
If still not tolerated:
Monitor response:
Important Caveats
Meta-regression did not find a relationship between iron dose and GI side effects, suggesting that side effects are inherent to the formulation rather than dose-dependent 2. This finding supports once-daily dosing strategies that maximize absorption while minimizing exposure frequency 1.
The marked heterogeneity in tolerability data (particularly in pregnant women, I² = 66.1%) suggests individual patient factors play a significant role 2, but the overall trend consistently favors ferric maltol for tolerability and ferrous sulfate for cost-effectiveness 1, 5.